Depression Center Leadership
The Depression Center Leadership (DCL) team establishes priorities and strategic direction for the Center, advises on organizational, operational, programmatic, and development goals, and guides the initiation and achievement of integrative University of Michigan and extramural collaborative relationships. The DCL advances the Depression Center’s interests and development by promoting and fostering the coordination and integration of activities with the Department of Psychiatry, in addition to other Health System and campus disciplines and advisory authorities across the institution.
|John Greden, M.D., Founder and Executive Director
Rachel Upjohn Professor of Psychiatry and Clinical Neurosciences
Research Professor, Molecular & Behavioral Neuroscience Institute
Founder and Chair, National Network of Depression Centers
Dr. John F. Greden is the Rachel Upjohn Professor of Psychiatry and Clinical Neurosciences in the Department of Psychiatry, Founder and Executive Director of the University of Michigan Depression Center, Founding Chair, National Network of Depression Centers (NNDC), and Research Professor in the Molecular and Behavioral Neuroscience Institute. He joined the faculty at the University of Michigan Medical School in 1974 and served as Chair of Michigan’s Department of Psychiatry from 1985 to 2007 when he stepped down to focus on directing the Depression Center and developing the NNDC.
Dr. Greden earned his B.S. and M.D. at the University of Minnesota, completed his internship at Harbor/UCLA, and his psychiatry residency at the University of Minnesota Hospitals and Walter Reed Army Medical Center in Washington, DC. He has authored or co-authored more than 400 articles, refereed abstracts, books, book chapters, and presented approximately 335 invited lectures. He has almost three decades of NIH funding as investigator, co-investigator and consultant. Major research themes have focused upon studying biomarkers and developing treatment strategies to prevent recurrences of depression and bipolar disorders. He has served as mentor for more than a dozen NIH or Veterans Administration “K” awardees and young investigators, and presented 10 keynote addresses for the American Psychiatric Association’s “Psychiatry Young Investigators’ Colloquium.”
To address the huge health burdens, disabilities and costs associated with clinical depressions, bipolar disorders, and related conditions, Dr. Greden proposed establishment of the country’s inaugural comprehensive Depression Center at the University of Michigan. Approved by the Regents in 2001, a new Depression Center-Ambulatory Psychiatry facility opened in 2006. The Center integrates research, clinical, educational and public policy efforts of more than 300 members from 13 University Schools and Colleges and 33 different University departments. Dr. Greden subsequently led efforts to establish similar centers throughout the country and integrate them into a National Network of Depression Centers patterned after the National Cancer Center Network. 16 eminent universities signed an NNDC Charter in a ceremony in Ann Arbor in October, 2008 and the NNDC has now grown to 21. Dr. Greden served as the Chair of the National Network of Depression Centers.
Dr. Greden is past-President of the Society of Biological Psychiatry; the Psychiatric Research Society; the American Association of Chairs of Departments of Psychiatry (AACDP); the Academic Psychiatry Consortium; and the Board of Directors of the American Foundation for Suicide Prevention . He edited the Journal of Psychiatric Research for seven years, chaired the Council on Research for the American Psychiatric Association for five years, served as Council Member of the American College of Neuropsychopharmacology (ACNP), Co-Chair of the National Psychiatry Training Council established by NIMH, and was selected as the 2005 recipient of the Distinguished Alumnus Award of the University of Minnesota Medical School. In 2013 the University of Michigan’s Council for Disability Concerns awarded Dr. Greden the James T. Neubacher Award.
|Gregory Dalack, M.D.
Associate Professor of Psychiatry
Chair of Psychiatry
Gregory W. Dalack is the Chair of the Department of Psychiatry. He came to the University of Michigan in 1992 where he initially was Chief of the Mental Health Clinic at the VA Ann Arbor Healthcare System (VAAAHS). From 1999-2005, he was Chief of the Psychiatry Service at VAAAHS. In 2005, he became Associate Chair for Education and Academic Affairs (a position he still holds) for the department. From 2006-2007, he was Vice Chair of the department until assuming the role of Interim Chair in 2007.
Dr. Dalack has had research interests in the treatment of chronic and persistent mental illnesses, particularly focusing on schizophrenia. He has conducted studies examining nicotine addiction and smoking cessation interventions in schizophrenia, health behaviors in schizophrenia, and metabolic effects of second-generation antipsychotic medications in schizophrenia.
Dr. Dalack received his medical degree from the College of Physicians and Surgeons of Columbia University, completed his internship in Medicine at the Presbyterian Hospital in the City of New York and his Psychiatry Residency at the New York State Psychiatric Institute (NYSPI). Also at Columbia and NYSPI, he completed a fellowship in Psychopharmacology.
|Carly Collins, MHA
Chief Department Administrator and UM Depression Center Administrator
Carly Collins joined the University of Michigan Department of Psychiatry and the UM Depression Center in the Fall of 2014 as the Chief Department Administrator and Administrator for the UM Depression Center. Ms. Collins earned her Master in Health Administration from Indiana University and a Bachelors of Science in Biology from Purdue University.
Prior to joining the University of Michigan, Ms. Collins held various administrative and finance positions, working in the departments of Neurosciences, Gynecology & Obstetrics and Psychiatry for Johns Hopkins Medicine. In those roles, she gained extensive experience in financial analysis and management, strategic planning, clinical operations and academic management. She now applies this skillset both at the Depression Center and in the Department of Psychiatry at the University of Michigan.
|Nancy Davis, B.A.
Associate Director, Neuroscience
Office of Development
|Patricia Deldin, Ph.D., Associate Director
Professor of Psychology, College of Literature, Science & the Arts
Professor of Psychiatry
Patricia Deldin is a professor of Psychology and an associate professor of Psychiatry at the University of Michigan. Following a two year research position at the National Institute of Mental Health (NIMH), Dr. Deldin received her Ph.D. from the University of Illinois, with a major in clinical psychology and a minor in biological psychology. She then completed an internship at the University of Wisconsin, Madison, Department of Psychiatry. Dr. Deldin was on the faculty of Harvard University (1995-2003) before coming to the University of Michigan in 2003.
Dr. Deldin is one of the associate directors of the Depression center and serves on the board of directors of the Society for Research in Psychopathology.
Her primary research program is comprised of information processing studies designed to distinguish memory, attention, and expectancy dysfunction in major depressives, dysthymics and controls. ERP, fMRI and behavioral studies provide complementary portraits of cognitive and emotional processing associated with depression.
|Rosalind Garcia-Tosi, Sc.D, M.PH., M.S.W.
Associate Director of Administration
Rosalind Garcia-Tosi joined the Depression Center in 2013 as the Associate Director of Administration. She holds “chief-of-staff” responsibilities for the Center – she provides administrative oversight, coordinates inter-disciplinary initiatives, monitors and implements initiatives and projects and she also provides strategic planning support. Dr. Garcia-Tosi also functions as principal liaison for the Executive Director and other faculty leadership within and outside of the organization.
Prior to joining the Depression Center, Dr. Garcia-Tosi held various positions at a children’s health center, including Director of Child and Adolescent Psychiatry, Director of Strategic Planning and Evaluation, and Chair of the Institutional Review Board. She has worked for a public health policy research organization evaluating maternal and child health programs. Dr. Garcia-Tosi earned her Doctor of Science in Health Systems Management from Tulane University’s School of Public Health and Tropical Medicine and holds a Master’s in Public Health in Health Management & Policy and a Master of Social Work in Administration from the University of Michigan. She has extensive expertise in program evaluation, maternal and child health, mental health, management, strategic planning, collaboration, health equity, and health disparities. Dr. Garcia-Tosi co-teaches a Cultural Competency in Healthcare course at the University of Michigan-Flint.
|Anne Harrington, Ph.D.
Since coming to the Ross School of Business at the University of Michigan in 1988 as a member of the Communication Faculty, Anne White Harrington has taught a variety of oral and written communication courses. She has participated in numerous special programs and events, including Global MBA, Executive MBA, Tauber Manufacturing Institute, and Erasmus Exchange programs. She is a founding faculty member and a Course Coordinator of the flagship MBA course, Multidisciplinary Action Projects (MAP), and has been the action learning project director for several Executive Education programs. In her role as Director of Instructional Development she supervises the PhD Teacher Development Program, offers Methods of Teaching courses, and provides workshops and coaching for faculty and doctoral students.
Professor Harrington received the Victor L. Bernard Faculty Leadership in Teaching Award in 1998 and the Ph.D. Award for Teaching Excellence in 2000. She earned a Master of Arts in Teaching from Northwestern University, a Master in Communication Arts from Michigan State University, and a Ph.D. in Communication from the University of Michigan.
Kori has worked at the University of Michigan Health System for the past thirteen years. In her previous position she supported the office of the Associate Director of Operations and Support Services. For the past 4 years, Kori has served as a parent advisor on a variety of venues within Mott’s PFCC Program as well as embedded PFCC coach for Operations and Support Services. Additionally, her experience has included work with various institutional PFCC efforts such as the Initial Clinical Experience training within the Medical School. She has presented both nationally and internationally on topics related to the importance of engaging patients and families in healthcare communication and the use of simulated-based training. Kori has played a major role in involving patients and families as key stakeholders in patient centered outcomes research (PCORI). She is a Patient and Stakeholder Reviewer, Mentor, and Ambassador, ensuring that patients and families have a voice in health care research . Kori earned her Bachelors of Business Administration from Eastern Michigan University and her Masters of Education with an emphasis in Performance Improvement from Wayne State University.
|Amy M. Kilbourne, Ph.D., M.PH.
Professor of Psychiatry, University of Michigan Medical School
Director, VA Quality Enhancement Research Initiative (QUERI) Program
Research Career Scientist, VA Ann Arbor Center for Clinical Management Research
Dr. Kilbourne is Professor of Psychiatry at the University of Michigan and is Director of the Quality Enhancement Research Initiative (QUERI) national program, U.S. Dept. of Veterans Affairs. Dr. Kilbourne is a national expert in collaborative care models for mood disorders and implementation science, including the design of implementation strategies (Enhanced Replicating Effective Programs) to promote the more rapid translation of research findings into actionable policy and practice. She also co-directs the UM Psychiatry Integrated Care Medicaid Match Program, which is focused on implementing and evaluating programs to improve physical and behavioral health services for Michigan residents.
Dr. Kilbourne has been widely recognized for her development of integrated treatment models for depression and bipolar disorders (Life Goals), cardiovascular risk reduction in mood disorders, measurement-based care, healthcare analytics, and health policy. Her research has led to several national improvement initiatives and policies across large healthcare systems, including a VA national population management program for persons with schizophrenia or bipolar disorders, a health disparities research roadmap, and a psychosocial intervention toolkit to improve physical and behavioral health outcomes for persons with mood disorders.
Dr. Kilbourne is the recipient of several awards including the prestigious Presidential Early Career Award for Scientists and Engineers (PECASE) and the Gerald L. Klerman Research Award from the Depression and Bipolar Support Alliance (DBSA). Dr. Kilbourne also serves on several national committees, including the Agency for Healthcare Research and Quality (AHRQ) DEcIDE Network for comparative effectiveness and patient-centered outcomes research, the National Institutes of Health (NIH) mental health services study section, and is a Senior Fellow with the Partnership for Public Service in Washington D.C. Dr. Kilbourne received her bachelors of arts at the University of California at Berkeley (double major in molecular biology and rhetoric), and her masters in epidemiology and PhD in health policy and administration from the University of California Los Angeles.
Melvin McInnis, M.D., Associate Director
Melvin G. McInnis, M.D., the Thomas B. and Nancy Upjohn Woodworth Professor of Bipolar Disorder and Depression, leads the University of Michigan’s clinical treatment and research group for Bipolar Disorder. Dr. McInnis, received his medical training at the University of Iceland, where he developed his interest in the genetics of bipolar disorder. He completed a psychiatric residency at the Bethlem Royal and Maudsley Hospitals at the University of London and then spent 15 years at Johns Hopkins University, where he became an associate professor and director of the George Brown Genetics Laboratory. Dr. McInnis has published more than 100 peer-reviewed articles on the genetics and clinical course of bipolar disorders. He is known as an expert in the diagnosis, genetics and clinical management of bipolar and depressive disorders in adolescents and adults.
Sagar V. Parikh, M.D., FRCPC, Associate Director
In March 2015, Dr. Sagar Parikh was appointed as the John F. Greden Professor of Depression and Clinical Neuroscience, and Professor of Psychiatry, at the University of Michigan, Ann Arbor, where he was also designated Associate Director of the Michigan Comprehensive Depression Center. Dr. Parikh is also Professor of Psychiatry at the University of Toronto, where he was on staff full-time from 1994-2015. In Toronto, he served as Director of Continuing Mental Health Education and Head of General Psychiatry, and at Toronto’s major hospital grouping, the University Health Network, he completed two terms as Deputy Psychiatrist-in-Chief and served as President of the Medical Staff Association and as a member of the Board of Trustees. Previously, he was head of the Bipolar Clinic and Director of CME at the Centre for Addiction and Mental Health (CAMH) in Toronto.
Dr. Parikh is the author / editor of two books and over 130 peer-reviewed articles and book chapters, and co-author of CANMAT treatment guidelines for Depression and for Bipolar Disorder, the world’s most cited mood disorder guidelines. He holds research grants from multiple funding agencies, covering studies in clinical treatments in mood disorders, health services research, genetics, epidemiology, and educational research. He has conducted clinical trials looking at the combination of medication and psychotherapy for bipolar disorder and for depression, as well as pharmacotherapy trials in mood disorders. Current major projects include a multi-site study of Biomarkers in Major Depression, Anti-Stigma interventions in Bipolar disorder, Workplace Depression interventions, and a RCT of Telephone-Delivered CBT for Bariatric Surgery patients. As medical director of Mensante, he helped create a novel internet system for recognition and management of mental disorders that is commercially marketed.
Dr. Parikh has a special interest in Continuing Education and Knowledge Translation research and delivery, having developed and tested novel CME programs to teach clinicians new skills to diagnose and treat mood disorders. He published a new theoretical model on how physicians learn and change practice behaviour in stages, and developed new toolkits and Knowledge Translation products as part of larger plan for treatment guideline dissemination. These interventions address multiple determinants of health by using multiple strategies—medication, psychotherapy, biomarkers, education—directed towards multiple targets, namely patients, providers, and systems.
Dr. Parikh was awarded the Dave Davis CEPD Research Award from the University of Toronto in 2008 and the R.O. Jones Award for Best Research Paper by the Canadian Psychiatric Association in 2011. He serves as Secretary of the International Society for Affective Disorders, and Co-Head, Section of Affective Disorders, World Psychiatric Association. He was honored by the Canadian Psychiatric Association by delivering the Distinguished Member Lecture at the 2007 CPA Annual Meeting. His teaching has won him three local, two national, and one international awards, most recently the Association of Chairs of Psychiatry Award for Excellence in Education.
Dr. Parikh’s education spans both the US and Canada, as a graduate of Phillips Academy, Andover; Columbia University (Bachelor of Science in Bioengineering); and McGill University Faculty of Medicine (M.D, C.M.).
He trained in Psychiatry at the University of Michigan, Ann Arbor and at the University of Toronto, and subsequently completed a two-year Research and Clinical Fellowship at the University of Toronto.
|Michelle Riba, M.D., M.S., Associate Director
Professor, Department of Psychiatry
Associate Chair for Integrated Medical and Psychiatric Services, Department of Psychiatry
Zonal Representative (Area 2, USA), World Psychiatric Association
Past President, American Psychiatric Association
Dr. Riba is Clinical Professor and Associate Chair for Integrated Medical and Psychiatric Services in the Department of Psychiatry, Associate Director of the University of Michigan Comprehensive Depression Center, and Director of the PsychOncology Program at the University of Michigan Comprehensive Cancer Center.
Dr. Riba’s clinical and research interests as a psychosomatic medicine psychiatrist include primary care psychiatry, depression and cardiovascular disease, depression and cancer, and the role of screening for distress in patients with cancer/medical illness. Dr. Riba is a Zonal Representative for the World Psychiatric Association and Past-President of the American Psychiatric Association, the Association for Academic Psychiatry, and the American Association of Directors of Psychiatric Residency Training.
As director of the University of Michigan Comprehensive Cancer Center PsychOncology Program, Dr. Riba leads a multidisciplinary group of clinicians who care for the emotional needs of cancer patients and their families; including physicians, nurses, social workers, art therapists, child life specialists and psychologists. Through numerous scientific papers, APA courses, books, and presentations at scientific meetings, she continues to advance the dialogue and research in this important clinical area nationally and internationally.
Dr. Riba is the author or editor of over 100 scientific articles, books, chapters and scientific abstracts. She has served on the editorial board of Psychiatric Services and Cancer News on the Net, Current Psychiatry and has served on the editorial advisory board of the American Psychiatric Press, Inc. She is a reviewer for Psycho-Oncology; Academic Psychiatry; Psychiatric Services; Journal of Psychiatric Practice; and Psychosomatic Medicine; Breast Cancer Research and Treatment. She has co-edited 15 editions of The American Psychiatric Press Review of Psychiatry series. She has co-edited Psychopharmacology and Psychotherapy: A Collaborative Approach; Primary Care Psychiatry; and The Doctor-Patient Relationship in Pharmacotherapy: Improving Treatment Effectiveness and has edited or co-written another 15 books.